|
End-of-day quote
Shenzhen S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 9.020 CNY | -3.53% |
|
-13.60% | +13.60% |
| 08-25 | Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026 | CI |
| 08-24 | Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 5.07B 754M 650M 609M 556M 1.05B 72.05B 1.05B 7.23B 2.82B 36.37B 2.83B 2.77B 121B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.9B 729M 628M 589M 538M 1.01B 69.66B 1.02B 6.99B 2.73B 35.16B 2.74B 2.68B 117B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | -3.53% | ||
| 1 week | -13.60% | ||
| Current month | +15.49% | ||
| 1 month | +18.53% | ||
| 3 months | +10.00% | ||
| 6 months | -8.98% | ||
| Current year | +13.60% |
| 1 week | 8.99 |  | 10.2 |
| 1 month | 7.76 | | 10.72 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.53% | -13.60% | -7.49% | +42.95% | 780M | |
| -0.13% | -6.44% | +60.34% | +114.35% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.71% | 646B | |
| -1.03% | -3.58% | +21.43% | +72.25% | 451B | |
| -1.05% | -4.27% | +36.28% | +36.23% | 355B | |
| -0.34% | -2.84% | +21.29% | +37.90% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -1.05% | -1.57% | +50.30% | +67.68% | 234B | |
| -1.27% | -2.89% | -20.41% | -54.38% | 203B | |
| -2.14% | -0.30% | +28.95% | +87.59% | 181B | |
| Average | -0.81% | -3.15% | +24.35% | +47.98% | 366.01B | |
| Weighted average by Cap. | -0.41% | -3.46% | +37.78% | +65.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 146M 126M 118M 108M 203M 13.97B 204M 1.4B 547M 7.05B 549M 537M 23.39B | 1.21B 179M 154M 145M 132M 249M 17.12B 250M 1.72B 670M 8.64B 673M 658M 28.66B |
| Net income | 13.65M 2.03M 1.75M 1.64M 1.5M 2.82M 194M 2.83M 19.45M 7.59M 97.89M 7.62M 7.45M 325M | 92.73M 13.78M 11.88M 11.14M 10.17M 19.15M 1.32B 19.21M 132M 51.55M 665M 51.75M 50.62M 2.2B |
| Net Debt | 189M 28.1M 24.22M 22.71M 20.73M 39.05M 2.69B 39.17M 269M 105M 1.36B 106M 103M 4.5B | -169M -25.09M -21.62M -20.27M -18.5M -34.86M -2.4B -34.97M -241M -93.84M -1.21B -94.2M -92.15M -4.01B |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | CN¥9.020 | -3.53% | 45,672,222 |
| 27/08/26 | CN¥9.350 | -1.27% | 50,740,045 |
| 26/08/26 | CN¥9.470 | -2.47% | 59,229,406 |
| 25/08/26 | CN¥9.710 | -0.31% | 68,281,012 |
| 24/08/26 | CN¥9.740 | -6.70% | 113,432,369 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
